Literature DB >> 16382882

The marrow cell continuum: stochastic determinism.

P Quesenberry1, M Abedi, M Dooner, G Colvin, F Martin Sanchez-Guijo, J Aliotta, J Pimentel, G Dooner, D Greer, D Demers, P Keaney, A Peterson, L Luo, B Foster.   

Abstract

Traditional models of hematopoiesis have been hierarchical in nature. Over the past 10 years, we have developed data indicating that hematopoiesis is regulated in a continuum with deterministic and stochastic components. We have shown that the most primitive stem cells, as represented by lineage negative rhodamine(low) Hoechst(low) murine marrow cells are continuously or intermittently cycling as determined by in vivo BrdU labeling. When marrow stem cells are induced to transit cell cycle by in vitro exposure to cytokines, either IL-3, IL-6, IL-11, and steel factor or thrombopoietin, FLT3 ligand, and steel factor, they progress through cycle in a highly synchronized fashion. We have determined that when the stem cells progress through a cytokine stimulated cell cycle the homing, engraftment, adhesion protein, global gene expression, and hematopoietic differentiation phenotypes all change in a reversible fashion. This has led to the continuum model, in which, with cycle transit, chromatin is continually changing altering open transcription areas and providing a continually changing landscape of transcriptional opportunity. More recently, we have extended the changing differentiation profiles to differentiation into lung cells and found that non-hematopoietic differentiation also shows cycle related reversibly modulation. These observations all together support a continuum model of stem cell regulation in which the phenotype of the marrow stem cells is continually and reversibly changing over time.

Entities:  

Mesh:

Year:  2005        PMID: 16382882

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  5 in total

1.  Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles.

Authors:  Jason M Aliotta; David Lee; Napoleon Puente; Sam Faradyan; Edmund H Sears; Ashley Amaral; Laura Goldberg; Mark S Dooner; Mandy Pereira; Peter J Quesenberry
Journal:  Stem Cells Dev       Date:  2012-02-15       Impact factor: 3.272

Review 2.  Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles.

Authors:  Peter J Quesenberry; Mark S Dooner; Jason M Aliotta
Journal:  Exp Hematol       Date:  2010-04-09       Impact factor: 3.084

Review 3.  Hematopoiesis and its disorders: a systems biology approach.

Authors:  Zakary L Whichard; Casim A Sarkar; Marek Kimmel; Seth J Corey
Journal:  Blood       Date:  2010-01-26       Impact factor: 22.113

4.  Perspectives on the Potential Therapeutic Uses of Vesicles.

Authors:  Giovanni Camussi; Peter J Quesenberry
Journal:  Exosomes Microvesicles       Date:  2013

Review 5.  Genetic communication by extracellular vesicles is an important mechanism underlying stem cell-based therapy-mediated protection against acute kidney injury.

Authors:  Lingfei Zhao; Chenxia Hu; Ping Zhang; Hua Jiang; Jianghua Chen
Journal:  Stem Cell Res Ther       Date:  2019-04-17       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.